A strategy for assessment and validation of major bleeding cases in a primary health care database in Spain

Purpose This study aims to validate major bleeding (MB) cases within a cohort of new users of direct oral anticoagulants (DOACs) in Electronic health records (EHRs) from primary care in Spain (BIFAP), introducing more efficient techniques and automating the process of validation in the pharmacoepide...

Full description

Saved in:
Bibliographic Details
Published inPharmacoepidemiology and drug safety Vol. 30; no. 12; pp. 1696 - 1702
Main Authors Burgos‐Gonzalez, Airam, Bryant, Verónica, Maciá‐Martinez, Miguel Angel, Huerta, Consuelo
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Inc 01.12.2021
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN1053-8569
1099-1557
1099-1557
DOI10.1002/pds.5357

Cover

More Information
Summary:Purpose This study aims to validate major bleeding (MB) cases within a cohort of new users of direct oral anticoagulants (DOACs) in Electronic health records (EHRs) from primary care in Spain (BIFAP), introducing more efficient techniques and automating the process of validation in the pharmacoepidemiologic research with EHR data as much as possible. Methods Registered bleedings were identified in a cohort of new users of DOACs in BIFAP using ICPC 2 and ICD 9 codes; we ascertained these bleedings as MB through a validation strategy based on the MB definition from the International Society on Thrombosis and Hemostasis, which used hospitalization and critical localization as proxies. We assessed hospitalization with hospital discharge information (only available for some years and regions) and a free text‐based algorithm created to identify hospitalization in EHR's clinical notes. Incidence rates (IR) of MB were evaluated by bleeding type. Results The study cohort included 104 614 patients, with 274521.5 p‐y of follow up. There were 6143 registered bleedings during the study period (519 intracranial bleeding – ICB, 4606 gastrointestinal bleeding – GIB, 1018 extracranial bleeding – ECB), from which 1679 were confirmed as MB (416 ICB, 1086 GIB, and 177 ECB). The free text‐based semi‐automatic algorithm had moderate recall (0.59), but high specificity (0.99), and precision (0.94). Conclusion The combination of hospitalization and critical localization is a valid approach to validate MB in EHRs with incomplete information. The use of more automatic methods for case validation instead of manual review of clinical notes is favored.
Bibliography:Funding information
This article is part of the project “Asociación entre el uso de estatinas y sangrado mayor y accidente cerebrovascular isquémico en pacientes en tratamiento con anticoagulantes de acción directa por fibrilación auricular” (“Association between statins use and major bleeding and ischemic stroke in patients taking direct oral anticoagulant for atrial fibrillation”), which has received funding from the national Tender Proyectos de Investigación en Salud (Modalidad Proyectos de Investigación en Salud), 2017, Acción Estratégica de Salud 2013–2017. Reference: PI17/02091. This study is based on data from the “Base de datos para la Investigación Farmacoepidemiológica en Atención Primaria” (BIFAP). BIFAP is a public program for independent research financed by the Spanish Agency for Medicines and Medical Devices (AEMPS).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1053-8569
1099-1557
1099-1557
DOI:10.1002/pds.5357